Skip to main content
. 2018 Aug 29;13:4869–4880. doi: 10.2147/IJN.S166769

Table S2.

The apoptosis rate of each group in BxPC-3 and SW1990 cell lines

Group BxPC-3
SW1990
Early apoptosis rate (%) Late apoptosis rate (%) Total apoptosis rate (%) Early apoptosis (%) Late apoptosis (%) Total apoptosis (%)
Control 4.71 ± 0.44 10.64 ± 1.16 15.35 ± 0.71 3.10 ± 0.41 9.41 ± 1.16 12.51 ± 0.97
NBMPR 4.58 ± 0.35 10.90 ± 1.81 15.48 ± 1.55 3.06 ±0.21 9.46 ± 0.91 12.52 ± 0.73
GEM 6.20 ± 0.94 19.23 ± 1.19 25.43 ± 1.69 7.22 ± 0.31 29.11 ± 1.31 36.33 ± 1.30
GEM + NBMPR 4.18 ± 0.37 10.38 ± 0.86 14.56 ± 1.09 3.16 ± 0.37 10.61 ± 1.20 13.77 ± 0.93
GEM-C14 7.29 ± 0.94 19.60 ± 0.78 26.89 ± 1.19 8.15 ± 0.81 21.95 ± 2.15 30.10 ± 1.34
GEM-C14 + NBMPR 8.49 ± 0.43 19.44 ± 1.88 27.93 ± 1.45 4.65 ± 1.19 21.33 ± 3.57 25.98 ± 2.41
GEM-HSA-NP 7.55 ± 0.69 21.41 ± 1.10 28.96 ± 1.11 6.54 ± 1.51 24.48 ± 1.26 31.02 ± 1.72
GEM-HSA-NP + NBMPR 8.78 ± 0.78 22.67 ± 0.78 31.45 ± 0.94 8.31 ± 0.97 24.73 ± 2.48 33.04 ± 1.59

Note: Data are expressed as mean ± SD.

Abbreviations: GEM, gemcitabine; GEM-C14, 4-N-myristoyl-gemcitabine; GEM-HSA-NP, gemcitabine-loaded human serum albumin nanoparticle; NBMPR, S-(4-nitrobenzyl)-6-thioinosine.